The board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited announced that Ms. Lin Man has resigned as an executive director, the chief operating officer, member of competition executive committee and authorised representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited with effect from 12 September 2023, due to personal endeavours.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.49 HKD | -1.15% | +5.09% | -21.83% |
Mar. 29 | Beijing Tong Ren Tang Chinese Medicine CEO Steps Down; Acting CEO Appointed | MT |
Mar. 28 | Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.83% | 1.03B | |
+26.12% | 661B | |
+26.74% | 566B | |
-6.72% | 352B | |
+19.49% | 332B | |
+3.32% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.47% | 145B |
- Stock Market
- Equities
- 3613 Stock
- News Beijing Tong Ren Tang Chinese Medicine Company Limited
- Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Resignation of Lin Man as Executive Director, Chief Operating Officer, Member of Competition Executive Committee